Strides acquires USFDA approved manufacturing facility in the US for US$  0.5  Million 

0 22,289

Bangalore : Strides Pharma Science Limited (Strides) on Tuesday announced that its step  down  subsidiary  Strides  Pharma  Inc.(SPI)  has  acquired  a  USFDA(FDA)  approved  manufacturing  facility  in  Florida, US from Micelle BioPharma, Inc.  for a  consideration  of  US$  0.5  Million . SPI has plans to  invest  up  to  US$  10  Million  to  build  incremental  capabilities and add additional dosage formats. With the addition of the Florida site, Strides now has eight formulation sites globally catering to the regulated and emerging markets.

Micelle’s facility is based in Riviera Beach, Florida and is one of the very few manufacturing facilities in the US with a soft gel capsule (SGC) manufacturing suite for formulations with containment needs.  It is also the  only  FDA  approved  integrated  manufacturing‐packaging  SGC  facility  in  the  US.  The site has undergone several successful FDA inspections and has no outstanding FDA observations.

Leave A Reply

Your email address will not be published.